Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

MOPH Mobile Application

 

“Haak bi Idak… Wajebna nfidik”

Under the theme “Haak bi Idak… Wajebna nfidik”, the minister of Public Health Ali Hasan Khalil launched this afternoon the first mobile application within the national E-Health programme. This app aims at providing general services through the dissemination of information related to the services provided by the Ministry of Public Health and the way to access them with modern ICT and social media.

The Director of the national E-Health programme Mrs. Lina Abou Mrad introduced the goals and applications of the programme that grants every citizen the right to access the suitable information from the administration to get the required service. The application enables the citizen to keep informed on the prices of registered drugs and the conditions of benefiting from the drugs provided by the Ministry for chronic or incurable diseases … a guide for the governmental and private hospitals, the names of the inspection doctors working for them, the primary health care centers, the awareness campaigns of the ministry, the section of complaints, the links to the website, the sanitary materials uploaded to You Tube and all the activities of the ministry… in the best and fastest possible means. It activates as well the accountability through the adoption of a procedure to lodge complaints.

The head of Medical Professions Department Antoine Romanos then introduced projects to enhance and facilitate the procedures at the ministry through this application, most important of which: the improvement of the conduct of procedures and the related regulations, the adoption of transparency to improve the public service, a better understanding of the citizens’ needs, the simplification of procedures to end the unnecessary or expensive forms of regulation, the use of the ICT STOP SHOP, the review of the rules and regulations to keep up with the administrative development and the introduction of the ONE stop Shop for the administrative transactions…

Minister Khalil noted that the meeting is to renew the confidence that has always existed in the state and institutions and their ability to accomplish great achievements. This is one the achievements of the Ministry of Public health’s team, administrators and employees. However it was clear that when the idea of the introduction of this app was advanced for the service of the Lebanese citizen, a team of administrators was fully ready. Khalil commended the role of Mrs. Abou Mrad and her commitment to provide all the necessary data for the application.

Minister Khalil handed out certificates of recognition to those who contributed in the completion of the work.
 
To download the mobile app:
 
On
 Google Play or  App Store
OR  For more information:
 
    ...
    7
    ...
ATC Name B/G Ingredients Dosage Form Price
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 80mg/4ml 80mg/4ml Injectable concentrated solution+diluent 24,150,868 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 20mg/ml 20mg/ml Injectable concentrated solution+diluent 6,574,078 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 20mg/ml 20mg/ml Injectable concentrated solution+diluent 6,574,078 L.L
L01CE01 TOPOTU G Topotecan HCl - 4mg/4ml 4mg/4ml Injectable concentrated solution 7,253,796 L.L
L01EA03 TASIGNA B Nilotinib - 200mg 200mg Capsule 412,535,139 L.L
L01EA03 TASIGNA B Nilotinib - 150mg 150mg Capsule 323,961,910 L.L
L01EA03 TASIGNA B Nilotinib - 150mg 150mg Capsule L.L
L01EA03 TASIGNA B Nilotinib - 200mg 200mg Capsule L.L
L01EB02 TARESSA 100 G Erlotinib (HCl) - 100mg 100mg Tablet, film coated 82,247,256 L.L
L01EB02 TARESSA 150 G Erlotinib (HCl) - 150mg 150mg Tablet, film coated 98,617,813 L.L
L01EB04 TAGRISSO B Osimertinib - 80mg 80mg Tablet, film coated 603,192,941 L.L
L01EB04 TAGRISSO B Osimertinib - 80mg 80mg Tablet, film coated L.L
L01EH01 TYKERB B Lapatinib ditosylate - 250mg 250mg Tablet, film coated 101,971,611 L.L
L01FA01 TRUXIMA BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 31,102,895 L.L
L01FA01 TRUXIMA BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 69,144,591 L.L
L01FD01 TRASTUREL BioTech Trastuzumab - 440mg 440mg Injectable lyophilised powder L.L
L01FD01 TRASTUREL BioTech Trastuzumab - 440mg 440mg Injectable lyophilised powder 52,047,114 L.L
L01FD01 TRAZIMERA BioTech Trastuzumab - 440mg 440mg Injectable powder for solution+solvent 75,295,202 L.L
L01FD01 TRAZIMERA BioTech Trastuzumab - 150mg 150mg Injectable powder for solution 28,550,630 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution 375,054,619 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution 375,054,619 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1875mg/15ml 1875mg/15ml Injectable solution 375,054,619 L.L
L01FX24 TECVAYLI BioTech Teclistamab - 10mg/ml 10mg/ml Injectable solution 95,166,436 L.L
L01FX24 TECVAYLI BioTech Teclistamab - 90mg/ml 90mg/ml Injectable solution 483,720,518 L.L
L01FX24 TECVAYLI BioTech Teclistamab - 90mg/ml 90mg/ml Injectable solution L.L
L01FX29 TALVEY B Talquetamab - 2mg/ml 3mg/1.5ml Injectable solution 45,594,403 L.L
L01FX29 TALVEY B Talquetamab - 40mg/ml 40mg/ml Injectable solution 555,916,745 L.L
L01XK04 TALZENNA B Talazoparib - 1mg 1mg Capsule 401,512,167 L.L
L01XK04 TALZENNA B Talazoparib - 0.25mg 0.25mg Capsule 133,836,699 L.L
    ...
    7
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025